Also trades as: DCAL.BO (BSE) · $vol 0M
DCAL.NS NSE
Dishman Carbogen Amcis Limited
1W: -10.6%
1M: -17.3%
3M: -23.5%
YTD: -28.4%
1Y: -43.8%
3Y: -1.8%
5Y: -29.3%
₹151.07 ($1.57)
+0.72 (+0.48%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
#8
of 21
Biotechnology
Technical Signal Map
4 Bullish
0 Neutral
9 Bearish
DCAL.NS
$23B
Dishman Carbogen Amcis Limited
BEARISH
-91
FERMENTA.BO
$16B
Fermenta Biotech Ltd.
BULLISH
+100
3BBLACKBIO.BO
$14B
3B BlackBio Dx Ltd
BULLISH
+91
ZOTA.NS
$38B
Zota Health Care Limited
BULLISH
+53
HALEOSLABS.NS
$4.5B
Haleos Labs Limited
LEAN BULL
+22
CONCORDBIO.NS
$144B
Concord Biotech Limited
LEAN BEAR
-16
TITANBIO.BO
$16B
Titan Biotech Limited
BEARISH
-42
ANTHEM.NS
$481B
Anthem Biosciences Ltd.
BEARISH
-44
BIOCON.NS
$506B
Biocon Limited
BEARISH
-62
SYNGENE.NS
$145B
Syngene International Limited
BEARISH
-75
BLUEJET.NS
$94B
Blue Jet Healthcare Limited
BEARISH
-84
ONESOURCE.NS
$173B
Onesource Specialty Pharma Ltd.
BEARISH
-91
PANACEABIO.NS
$22B
Panacea Biotec Limited
BEARISH
-91
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| DCAL.NS Dishman Carbogen Amcis Limited | $23B | 35.1 | 1.6 | 2.4 | 2.6 | 8.1 | 5 | BEARISH | -43.8 |
| FERMENTA.BO Fermenta Biotech Ltd. | $16B | 26.6 | 29.5 | 22.8 | 8.0 | 50.1 | 6 | BULLISH | 53.3 |
| 3BBLACKBIO.BO 3B BlackBio Dx Ltd | $14B | — | — | — | — | — | — | BULLISH | — |
| ZOTA.NS Zota Health Care Limited | $38B | -40.3 | -16.1 | -5.8 | -8.7 | 83.9 | 5 | BULLISH | -5.3 |
| HALEOSLABS.NS Haleos Labs Limited | $4.5B | — | — | — | — | — | — | LEAN BULL | — |
| CONCORDBIO.NS Concord Biotech Limited | $144B | 52.5 | 13.6 | 16.0 | 27.2 | -12.1 | 5 | LEAN BEAR | -15.8 |
| TITANBIO.BO Titan Biotech Limited | $16B | 47.4 | 17.8 | 13.4 | 13.8 | 31.8 | 5 | BEARISH | -11.0 |
| ANTHEM.NS Anthem Biosciences Ltd. | $481B | — | — | — | — | — | — | BEARISH | 13.3 |
| BIOCON.NS Biocon Limited | $506B | 108.3 | 1.4 | 5.2 | 2.8 | 10.7 | 6 | BEARISH | 2.9 |
| SYNGENE.NS Syngene International Limited | $145B | 65.3 | 6.6 | 15.8 | 14.3 | 2.6 | 5 | BEARISH | -45.2 |
| BLUEJET.NS Blue Jet Healthcare Limited | $94B | 39.9 | 19.9 | 19.6 | 27.4 | -8.0 | 4 | BEARISH | -31.2 |
| ONESOURCE.NS Onesource Specialty Pharma Ltd. | $173B | — | — | — | — | — | — | BEARISH | -20.5 |
| PANACEABIO.NS Panacea Biotec Limited | $22B | -308.6 | -0.6 | -3.8 | 0.3 | 14.4 | 2 | BEARISH | -14.6 |
| DCAL.NS Dishman Carbogen Amcis Limited | $23B | 35.1 | 1.6 | 2.4 | 2.6 | 8.1 | 5 | BEARISH | -43.8 |
| FERMENTA.BO Fermenta Biotech Ltd. | $16B | 26.6 | 29.5 | 22.8 | 8.0 | 50.1 | 6 | BULLISH | 53.3 |
| 3BBLACKBIO.BO 3B BlackBio Dx Ltd | $14B | — | — | — | — | — | — | BULLISH | — |
| ZOTA.NS Zota Health Care Limited | $38B | -40.3 | -16.1 | -5.8 | -8.7 | 83.9 | 5 | BULLISH | -5.3 |
| HALEOSLABS.NS Haleos Labs Limited | $4.5B | — | — | — | — | — | — | LEAN BULL | — |
| CONCORDBIO.NS Concord Biotech Limited | $144B | 52.5 | 13.6 | 16.0 | 27.2 | -12.1 | 5 | LEAN BEAR | -15.8 |
| TITANBIO.BO Titan Biotech Limited | $16B | 47.4 | 17.8 | 13.4 | 13.8 | 31.8 | 5 | BEARISH | -11.0 |
| ANTHEM.NS Anthem Biosciences Ltd. | $481B | — | — | — | — | — | — | BEARISH | 13.3 |
| BIOCON.NS Biocon Limited | $506B | 108.3 | 1.4 | 5.2 | 2.8 | 10.7 | 6 | BEARISH | 2.9 |
| SYNGENE.NS Syngene International Limited | $145B | 65.3 | 6.6 | 15.8 | 14.3 | 2.6 | 5 | BEARISH | -45.2 |
| BLUEJET.NS Blue Jet Healthcare Limited | $94B | 39.9 | 19.9 | 19.6 | 27.4 | -8.0 | 4 | BEARISH | -31.2 |
| ONESOURCE.NS Onesource Specialty Pharma Ltd. | $173B | — | — | — | — | — | — | BEARISH | -20.5 |
| PANACEABIO.NS Panacea Biotec Limited | $22B | -308.6 | -0.6 | -3.8 | 0.3 | 14.4 | 2 | BEARISH | -14.6 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
DCAL.NS vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F